Safety standards for medicines manufactured in China have been called into question after a former drug safety bureau director in the southern Chinese province of Guangdong was sentenced for taking bribes from more than two dozen pharmaceutical companies.
Cai Ming, former director of an office in charge of drug safety at the Guangdong Province Food and Drug Administration, was sentenced to eight years in prison and ordered to pay a fine of 400,000 yuan ($62,436) by the Guangzhou City Intermediate People’s Court, reported Chinese news portal Sina. He was convicted of accepting bribes totaling about 6.23 million yuan (about $973,725).
